tRNA Dysregulation in Neurodevelopmental and Neurodegenerative Diseases

被引:14
|
作者
Burgess, Robert W. [1 ]
Storkebaum, Erik [2 ]
机构
[1] Jackson Lab, Bar Harbor, ME 04609 USA
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
基金
荷兰研究理事会; 美国国家卫生研究院; 欧洲研究理事会;
关键词
tRNA; aminoacyl tRNA synthetase; tRNA modification; tRNA splicing; angiogenin; integrated stress response; MUTANT TRANSFER-RNA; MITOCHONDRIAL-DNA MUTATION; TRANSFER RNALEU(UUR) GENE; SYNTHETASE MUTATIONS; LACTIC-ACIDOSIS; POINT MUTATION; PONTOCEREBELLAR HYPOPLASIA; COMPOUND HETEROZYGOSITY; ANGIOGENIN VARIANTS; MYOCLONIC EPILEPSY;
D O I
10.1146/annurev-cellbio-021623-124009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transfer RNAs (tRNAs) decode messenger RNA codons to peptides at the ribosome. The nuclear genome contains many tRNA genes for each amino acid and even each anticodon. Recent evidence indicates that expression of these tRNAs in neurons is regulated, and they are not functionally redundant. When specific tRNA genes are nonfunctional, this results in an imbalance between codon demand and tRNA availability. Furthermore, tRNAs are spliced, processed, and posttranscriptionally modified. Defects in these processes lead to neurological disorders. Finally, mutations in the aminoacyl tRNA synthetases (aaRSs) also lead to disease. Recessive mutations in several aaRSs cause syndromic disorders, while dominant mutations in a subset of aaRSs lead to peripheral neuropathy, again due to an imbalance between tRNA supply and codon demand. While it is clear that disrupting tRNA biology often leads to neurological disease, additional research is needed to understand the sensitivity of neurons to these changes.
引用
收藏
页码:223 / 252
页数:30
相关论文
共 50 条
  • [21] Modelling neurodevelopmental and neurodegenerative diseases for prognosis, diagnosis, and therapies
    Vilain, Sven
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [22] Editorial: Predictive Imagable Biomarkers for Neurodegenerative and Neurodevelopmental Diseases
    Mandal, Pravat K.
    Ersland, Lars
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [23] Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
    Vance, Jean E.
    DISEASE MODELS & MECHANISMS, 2012, 5 (06) : 746 - 755
  • [24] Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases
    Afridi, Ruqayya
    Rahman, Md Habibur
    Suk, Kyoungho
    NEUROBIOLOGY OF DISEASE, 2022, 174
  • [25] Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases
    Zheng, Qiuyang
    Huang, Timothy
    Zhang, Lishan
    Zhou, Ying
    Luo, Hong
    Xu, Huaxi
    Wang, Xin
    FRONTIERS IN AGING NEUROSCIENCE, 2016, 8
  • [26] The tRNA-associated dysregulation in immune responses and immune diseases
    Zhu, Chunsheng
    Sun, Bao
    Nie, Anzheng
    Zhou, Zheng
    ACTA PHYSIOLOGICA, 2020, 228 (02)
  • [27] Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases
    Uittenbogaard, Martine
    Chiaramello, Anne
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (35) : 5574 - 5593
  • [28] IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases
    Alberini, Cristina M.
    TRENDS IN NEUROSCIENCES, 2023, 46 (06) : 488 - 502
  • [29] Three-Dimensional Models for Studying Neurodegenerative and Neurodevelopmental Diseases
    Tsaridou, Stavroula
    Skamnelou, Margarita
    Iliadou, Marianna
    Lokka, Georgia
    Parlapani, Evangelia
    Mougkogianni, Maria
    Danalatos, Rodolfos-Iosif
    Kanellou, Anastasia
    Chlorogiannis, Dimitris-David
    Kyrousi, Christina
    Taraviras, Stavros
    GENEDIS 2018: GENETICS AND NEURODEGENERATION, 2020, 1195 : 35 - 41
  • [30] Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases
    Flores-Dorantes, Maria Teresa
    Diaz-Lopez, Yael Efren
    Gutierrez-Aguilar, Ruth
    FRONTIERS IN NEUROSCIENCE, 2020, 14